Theranostic Potential of Metal–Organic Framework/Polydopamine-Modified Magnetic Nanoparticles for Photothermal/Chemotherapy and MR Imaging
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c00702 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Elnaz Mohammadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Metallurgy and Materials Engineering, College of Engineering, University of Tehran, P.O. Box: 111554563 Tehran, Iran. Hauptthemen laut MEDLINE: Indoles, Polymers, Theranostic Nanomedicine, Magnetic Resonance Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Theranostic nanoparticles that integrate therapeutic and diagnostic functions in one system offer significant potential for cancer treatment. The present study aimed to develop a theranostic hybrid nanosystem based on cobalt ferrite (CFO), polydopamine (PDA), and UiO-66-NH2 (UiO) metal organic framework, to be used for magnetic resonance imaging (MRI) applications and synergistic photothermal therapy (PTT)/chemotherapy. Material characterizations confirmed that a nanostructure with a mean diameter of less than 100 nm has been successfully constructed. Due to the CFO component, the CFO@PDA@UiO demonstrated a relaxivity of 101.3 mM–1. s–1, showing potential as a T2-weighted contrast agent. PDA improved the photothermal conversion capability of the CFO@PDA@UiO hybrid nanosystem, increasing the medium temperature within the hyperthermia therapy range. The UiO shell also acted as a carrier for the anticancer drug Gemcitabine (GEM). Ultraviolet–visible (UV–vis) spectroscopy analysis estimated that nanoparticles have a loading capacity of about 17.59% and approximately 30% of GEM was released at acidic pH (5.5). Drug-loaded nanoparticles demonstrated excellent hemocompatibility, with less than 5% hemolysis at concentrations up to 500 μg/mL. Compared to the free GEM, CFO@PDA@UiO-GEM exhibited more effective anticancer activity against MCF-7 cancer cells under NIR laser irradiation. As a result, the synthesized CFO@PDA@UiO hybrid nanosystem showed great potential as a candidate for cancer theranostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Metallurgy and Materials Engineering, College of Engineering, University of Tehran, P.O. Box: 111554563 Tehran, Iran.
- Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box: 143951374 Tehran, Iran.
- Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box: 141556451 Tehran, Iran.
- Department of Physics, K. N. Toosi University of Technology, P.O. Box: 158754416 Tehran, Iran.
ORCID-Profile: Fatemehsadat Pishbin, Azadeh Ghaee
Zitieren
APA
Mohammadi, E., Pishbin, F., Ghaee, A., Akrami, M., & Rezaei, F. (2025). Theranostic Potential of Metal–Organic Framework/Polydopamine-Modified Magnetic Nanoparticles for Photothermal/Chemotherapy and MR Imaging. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00702
Vancouver
Mohammadi E, Pishbin F, Ghaee A, Akrami M, Rezaei F. Theranostic Potential of Metal–Organic Framework/Polydopamine-Modified Magnetic Nanoparticles for Photothermal/Chemotherapy and MR Imaging. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00702
BibTeX
@article{Mohammadi2025,
author = {Mohammadi, Elnaz and Pishbin, Fatemehsadat and Ghaee, Azadeh and Akrami, Mohammad and Rezaei, Fatemeh},
title = {Theranostic Potential of Metal–Organic Framework/Polydopamine-Modified Magnetic Nanoparticles for Photothermal/Chemotherapy and MR Imaging},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c00702}
}
EUVIMED